Medifast (NYSE:MED – Get Free Report) and Oriental Rise (NASDAQ:ORIS – Get Free Report) are both small-cap consumer staples companies, but which is the superior business? Analyst RatingsThis is a summary of recent recommendations for Medifast and Oriental Rise, as provided by MarketBeat. Given Medifast’s stronger consensus rating and higher probable upside, equities analysts plainly believe Medifast is more favorable than Oriental Rise. Comparatively, Oriental Rise has a beta of 1.54, meaning that its share price is 54% more volatile than the S&P 500. Net Margins Return on Equity Return on Assets Medifast -5.78% -4.80% -3.83% Oriental Rise N/A N/A N/ASummaryMedifast beats Oriental Rise on 7 of the 12 factors compared between the two stocks.